Zhende Medical Co., Ltd. (SHA:603301)
81.73
+0.49 (0.60%)
Sep 14, 2026, 3:00 PM CST
Zhende Medical Revenue
Zhende Medical had revenue of 1.22B CNY in the quarter ending June 30, 2026, with 10.37% growth. This brings the company's revenue in the last twelve months to 4.45B, up 3.05% year-over-year. In the year 2025, Zhende Medical had annual revenue of 4.33B with 1.54% growth.
Revenue (ttm)
4.45B
Revenue Growth
+3.05%
P/S Ratio
4.84
Revenue / Employee
563.09K
Employees
7,909
Market Cap
21.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.33B | 65.71M | 1.54% |
| Dec 31, 2024 | 4.26B | 136.84M | 3.32% |
| Dec 31, 2023 | 4.13B | -2.01B | -32.76% |
| Dec 31, 2022 | 6.14B | 1.05B | 20.54% |
| Dec 31, 2021 | 5.09B | -5.31B | -51.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Intco Medical Technology | 11.92B |
| Winner Medical | 11.14B |
| Tofflon Science and Technology Group | 5.34B |
| Gan & Lee Pharmaceuticals. | 4.21B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.35B |
| iRay Group | 2.86B |
| Shenyang Xingqi Pharmaceutical | 2.71B |
| Imeik Technology Development | 2.37B |